In vitro and in vivo studies have demonstrated that suppressing the expression of the E2 ubiquitin conjugate CDC34 effectively hinders the proliferation of non-small cell lung cancer (NSCLC) cells. This evidence concerns the gene CDC34 and non-small cell lung carcinoma.